This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2017
Title: Chandan Hardhan Singh: Innovator in Pharmaceutical Compounds
Introduction
Chandan Hardhan Singh is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of two patents to his name, Singh is recognized for his work in developing novel compounds that address critical health issues.
Latest Patents
Singh's latest patents include the development of indole 3-carbinol derivatives. This invention relates to novel stable indole-3-carbinol derivatives of Formula-I, along with their pharmaceutical compositions and biological activities. The invention focuses on compositions and methods for the treatment and prevention of conditions associated with inflammation. Additionally, he has developed hypoglycemic compounds, which are novel amino acid derivatives of formula (1) and pharmaceutically acceptable salts thereof. This invention aims to provide effective solutions for managing blood sugar levels.
Career Highlights
Chandan Hardhan Singh is currently associated with Cadila Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Cadila Pharmaceuticals has allowed him to contribute to the development of innovative medical solutions that benefit patients worldwide.
Collaborations
Some of his notable coworkers include Rajiv Indravadan Modi and Bakulesh Mafatlal Khamar. Their collaboration has likely fostered an environment of innovation and creativity within the company.
Conclusion
Chandan Hardhan Singh's contributions to pharmaceutical innovations through his patents highlight his commitment to improving health outcomes. His work continues to inspire advancements in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile